Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2014
09/24/2014EP2779996A1 Drug delivery system for sustained delivery of bioactive agents
09/24/2014EP2779993A1 Autoclavable suspensions of cyclosporin a form 2
09/24/2014EP2779992A1 Sustained action formulation of cyclosporin form 2
09/23/2014US8841426 Mutant of granulocyte-colony stimulating factor (G-CSF) and chemically conjugated polypeptide thereof
09/23/2014US8841425 Cytotoxic agents comprising new maytansinoids
09/23/2014US8841417 IL-1 binding proteins
09/23/2014US8841351 Polymeric topical compositions
09/23/2014US8841345 Compositions and methods for treatment of premature ejaculation
09/23/2014US8841342 Carrier
09/23/2014US8841316 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
09/23/2014US8841261 Functional powdery product
09/23/2014US8841255 Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
09/23/2014US8840951 Method for preparation of a controlled release system
09/23/2014US8840932 Antiseptic compositions and methods
09/23/2014US8840931 Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues
09/23/2014US8840924 Compositions and methods of making rapidly dissolving ionically masked formulations
09/23/2014US8840915 Pharmaceutical compositions for sustained release delivery of peptides
09/23/2014US8840906 Methods and compositions related to immunizing against Staphylococcal lung disease and conditions
09/23/2014US8840884 Antibody-containing solution pharmaceuticals
09/23/2014US8840883 Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof
09/23/2014US8840879 Conjugates of hydroxyalkyl starch and a protein
09/23/2014US8840877 Polysaccharide-protein conjugates reversibly coupled via imine bonds
09/23/2014US8840874 Vascular delivery systems
09/23/2014US8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
09/23/2014CA2758460C Methods of preparing monodisperse oligo (ethylene glycol) reagent compositions
09/23/2014CA2756811C Liposome composition of eribulin or its pharmacologically permissible salt
09/23/2014CA2748860C Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
09/23/2014CA2715133C Fine powder of polyamide from renewable materials and method for making such powder
09/23/2014CA2683009C Use of il-18 inhibitors
09/23/2014CA2646934C Methods for reducing protein aggregation
09/23/2014CA2632544C Use of myostatin antagonist for treating the effects of hypogonadism
09/23/2014CA2589632C Injectable non-aqueous suspension
09/23/2014CA2534474C Methods for treating cardiovascular disease using a soluble ctla4 molecule
09/18/2014WO2014146077A1 Multi-stage biodegradable drug delivery platform
09/18/2014WO2014145755A1 Polyalkylene oxide valerate hemoglobin conjugates
09/18/2014WO2014145710A1 Parenteral diclofenac composition
09/18/2014WO2014145573A1 Coated magnetic nanoparticles for imaging enhancement and drug delivery
09/18/2014WO2014145308A1 Compositions and methods for delivering therapeutic and imaging agents to the sinuses and middle ear
09/18/2014WO2014145302A2 Synthesis of ent-progesterone and intermediates thereof
09/18/2014WO2014145285A1 Manufacturing process for effervescent dosage forms
09/18/2014WO2014145242A1 Peptide-coated polymer carriers
09/18/2014WO2014145093A1 Fine dry particulate resveratrol active agent compositions and topical formulations including the same
09/18/2014WO2014145090A1 Biologically active molecules, conjugates thereof, and therapeutic uses
09/18/2014WO2014145067A1 Topical compositions of flunisolide and methods of treatment
09/18/2014WO2014144911A2 Hybrid immunoglobulin containing non-peptidyl linkage
09/18/2014WO2014144888A1 Calcium sulfate-resin hybrid materials and methods of using and making the same
09/18/2014WO2014144793A1 Substituted silaxanthenium red to near-infrared fluorochromes for in vitro and in vivo imaging and detection
09/18/2014WO2014144651A2 An intelligent and configurable fluid delivery system and methods for its use
09/18/2014WO2014144621A2 Modified fc fusion proteins
09/18/2014WO2014144592A2 Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing
09/18/2014WO2014144421A1 Ceramide reversal of multi-drug resistance
09/18/2014WO2014144309A1 Sustained release microspheres and method of producing the same
09/18/2014WO2014144241A1 Sublingual and buccal film compositions
09/18/2014WO2014144178A1 Reduction in stress cracking of films
09/18/2014WO2014143839A1 High drug load buprenorphine microspheres and method of producing the same
09/18/2014WO2014143808A1 Hollow particles encapsulating a biological gas and methods of use
09/18/2014WO2014143781A1 Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
09/18/2014WO2014143765A1 Anti-egfr antibody drug conjugate formulations
09/18/2014WO2014143646A1 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014WO2014143635A1 Compositions of a polyorthoester and an aprotic solvent
09/18/2014WO2014143613A1 Methods of treatment of pediatric solid tumor
09/18/2014WO2014142915A1 Methods for producing a biodegradable chitosan composition and uses thereof
09/18/2014WO2014142653A1 Vaccination composition
09/18/2014WO2014142025A1 Compound having cyclopropane ring, and flavor composition containing same
09/18/2014WO2014142012A1 Ophthalmic composition for soft contact lens
09/18/2014WO2014141287A1 The art, method, manner, process and system of multifunctional nanobiomaterial for molecular imaging and drug- delivery
09/18/2014WO2014141223A1 Chewable formulation
09/18/2014WO2014141149A1 Formulations with reduced viscosity
09/18/2014WO2014141135A1 Respirable agglomerates of porous carrier particles and micronized drug
09/18/2014WO2014141121A1 Composition containing digestive enzymes and nutrients suitable for enteral administration
09/18/2014WO2014141094A1 Anticancer conjugate
09/18/2014WO2014140868A2 Xanthine oxidase inhibitor formulations
09/18/2014WO2014140645A1 Stable aqueous formulations of adenovirus vectors
09/18/2014WO2014140549A1 Cell delivery medium
09/18/2014WO2014140524A1 Pharmaceutical composition for the treatment of fungal infections
09/18/2014WO2014140507A1 Pharmaceutical composition for the treatment of fungal infections
09/18/2014WO2014140368A1 Antibody constructs for influenza m2 and cd3
09/18/2014WO2014140330A1 Anti-ddr1 internalizing antibodies and their medical use
09/18/2014WO2014140317A2 Method of producing an immunoligand/payload conjugate
09/18/2014WO2014140300A1 Solid phase tgase-mediated conjugation of antibodies
09/18/2014WO2014140231A1 Abuse resistant capsule
09/18/2014WO2014140222A1 Pegylated glucagon and glp-1 co-agonists for the treatment of obesity
09/18/2014WO2014140213A1 Taxoid - purification principle for liquid excipients
09/18/2014WO2014140203A1 Particles comprising luminescent lanthanide complexes
09/18/2014WO2014140174A1 Pyrrolobenzodiazepines and conjugates thereof
09/18/2014WO2014139677A1 Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof
09/18/2014WO2014139033A1 Compounds and compositions for drug release
09/18/2014WO2014138953A1 Treatment of endometriosis, angiogenesis and/or endometrial lesion growth
09/18/2014WO2014138937A1 A growth hormone secretagogue receptor based protein, nucleic acids and methods and uses thereof
09/18/2014WO2014138881A1 Drug delivery system
09/18/2014WO2014038963A9 Dendrimer scaffolds for pharmaceutical use
09/18/2014WO2013149159A9 Anti-lgr5 antibodies and immunoconjugates
09/18/2014US20140277570 Bone growth promotion systems and methods
09/18/2014US20140277112 Injectable hydrogels
09/18/2014US20140276483 Transdermal methylphenidate compositions with acrylic block copolymers
09/18/2014US20140276478 Compositions and methods for transdermal delivery of tertiary amine drugs
09/18/2014US20140275509 Multifunctionalized materials
09/18/2014US20140275479 Specific binding agents of human angiopoeitin-2
09/18/2014US20140275476 Crystalline insulin-conjugates
09/18/2014US20140275291 Biocompatible and bioabsorbable derivatized chitosan compositions
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 1712